CD44 and glioblastoma: In both the PBS-treated and the TMZ-treated groups, a number of CD44-positive glioblastoma cells were observed on the corpus callosum in the contralateral hemisphere, indicated with a yellow arrow, whereas the KIST-G1-treated brain showed no trace of CD44-positive cells in the contralateral brain region (Figure 6C).